Jasper Therapeutics, Inc. Common Stock (JSPR) is a publicly traded Healthcare sector company. As of July 17, 2026, JSPR trades at $0.81 with a market cap of $19.38M and a P/E ratio of -0.19. JSPR moved +15.58% today. Year to date, JSPR is -57.70%; over the trailing twelve months it is -76.90%. Its 52-week range spans $0.32 to $26.05. Analyst consensus is neutral with an average price target of $3.00. Rallies surfaces JSPR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for JSPR, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.81 |
| Market Cap | $19.38M |
| P/E Ratio | -0.19 |
| EPS | $-3.95 |
| Dividend Yield | 0.00% |
| 52-Week High | $26.05 |
| 52-Week Low | $0.32 |
| Volume | 790.65K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-75.80M |
| Gross Margin | 0.00% |
3 analysts cover JSPR: 0 strong buy, 0 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $3.00.